Related Experiment Videos
Rupture of an abdominal aortic aneurysm after endovascular graft placement and aneurysm size reduction
Insights
Abdominal aortic aneurysm rupture can occur even after successful endovascular graft placement and aneurysm size reduction. Biomaterial analysis of explanted grafts is crucial for understanding such rare events.
Area of Science:
- Vascular Surgery
- Biomaterials Science
- Medical Imaging
Background:
- Endovascular aneurysm repair (EVAR) is a common treatment for abdominal aortic aneurysms (AAAs).
- Aneurysm size reduction post-EVAR is a key indicator of successful treatment.
- Complications, though rare, can still occur despite favorable imaging findings.
Observation:
- A patient experienced a rupture of an abdominal aortic aneurysm 9 months after bifurcated endovascular graft placement.
- A significant aneurysm size reduction (>45%) was observed 7 months post-procedure via contrast-enhanced computed tomography.
- This case highlights a discrepancy between imaging-based success criteria and clinical outcomes.
Findings:
- The study analyzes biomaterial modifications of the endovascular stent and the explanted Dacron stent-graft.
- Investigating material degradation or changes may reveal factors contributing to late rupture.
- Understanding material behavior is essential for improving long-term EVAR safety.
Implications:
- This case challenges the sole reliance on aneurysm size reduction as a criterion for EVAR success.
- Further research into endograft biomaterials and long-term performance is warranted.
- Improved understanding may lead to enhanced graft designs and patient selection for EVAR.
Abstract:
Reduction in aneurysm size during the months after an endovascular graft placement generally is considered one of the criteria of success. We report the case of a patient with an abdominal aortic aneurysm rupture occurring 9 months after a bifurcated endovascular graft placement despite a greater than 45% reduction in size noted on contrast-enhanced computed tomography scan performed at 7 months. Biomaterial modifications of the stent and of the Dacron explanted stent-graft are analyzed.